Finasterid tedavisine rağmen hayatı tehdit edebilecek prostat kanaması: Olgu sunumu

Prostat kaynaklı kanamalar genellikle prostatın frajil, aşırı damarlanması sonucu gerçekleşir. Prostatın damarları herhangi bir nedenden dolayı yırtıldığında hasta spontan gross hematüri ile başvurabilir. Hastanın konforunu ve hayatını tehdit eden makroskopik, abondan, spontan hematüri olduğunda acil şartlarda değerlendirilmelidir. BPH benign prostat hiperplazisi bağlı gross hematürilerde TURP transüretral prostatektomi , diğer tedavi seçeneklerin yanında, obstruktif semptomları ağır basan hastalar için alternatif tedavi olarak düşünülmelidir

Anahtar Kelimeler:

Benign prostat hiperplazisi, hematüri, transüretral prostatektomi, tedavi

In spite of finasteride treatment prostatic bleeding that might threaten life: Case report

Bleeding of prostatic origin is usually caused by the fragile hypervascularity of the prostate, the vessels of which are easily disrupted and the patients might be accepted the hospital with gross hematuria. The spontan gross hematuria which negative effect to patients comfort and threat to live should be evaluated urgently. İn Gross hematuria due to BPH benign prostate hyperplasia along with the other treatment options TURP transurethral resection should be considered as an alternative treatment fort he patients withobstructive symptoms

Keywords:

Benign prostate hyperplasia, hematuria, transurethral resection of prostate, treatment,

PDF

___

AUA Practice Guideline Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol,170: 530–547, 2003.
Mebust WK, Holtgrewe HL, Cockett AT, et al. Transureth- ral prostatectomy: immediate and postoperative complica- tions. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol.,141:243-247, 1989.
Lynch TH, Waymont B, Dunn JA, et al.. Rapid diagnostic service for patients with haematuria. Br J Urol, 73: 147- 151, 1994.
Hasan ST, German K, Derry CD. Same day diagnosis of ha- ematuria. Br J Urol, 73:147-151, 1994.
Baroudy AC, O’Connell JP. Papillary adenoma of the pros- tatic urethra. J Urol.,132:120-122, 1984.
Stein AJ, Prioleau PG, Catalona WJ. Adenomatous polyps of the prostatic urethra: a cause of hematospermia. J Urol, 124: 298–299, 1980.
Aliabadi H, Cass AS, Gleich P. Utricular papilloma. Uro- logy, 29: 317–318, 1987.
Cattolica EV. Massive hemospermia: a new etiology and simplified treatment. J Urol,128: 151–152, 1982.
Cheng YS, Lin JS, Lin YM. Isolated posterior urethral in- jury: an unusual complication and presentation following male coital trauma. Asian J Androl, 8: 379–381, 2006.
Pareek G, Shevchuk M, Armenakas NA, et al. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mecha- nism for decreased prostatic bleeding in treated patients. J Urol, 169: 20–23, 2003.
Miller MI, Puchner PJ. Effects of finasteride on hematu- ria associated with benign prostatic hyperplasia: long-term follow- up. Urology; 51: 237–240, 1998.
Perimenis P, Gyftopoulos K, Markou S, et al. Effects of fi- nasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomi- zed, controlled study. Urology, 59: 373–377, 2002.
Appleton DS, Sibley GN, Doyle PT. Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol, 61(1): 45–47, 1988.
Clark RV, Hermann DJ, Cunningham GR, et al. Mar- ked suppression of dihydrotestosterone in men with be- nign prostatic hyperplasia by dutasteride, a dual 5alpha- reductase inhibitor. J Clin Endocrinol Metab, 89: 2179– 2184, 2004